1. Home
  2. INGN vs KALA Comparison

INGN vs KALA Comparison

Compare INGN & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inogen Inc

INGN

Inogen Inc

HOLD

Current Price

$7.05

Market Cap

172.4M

Sector

Health Care

ML Signal

HOLD

Logo KALA BIO Inc.

KALA

KALA BIO Inc.

HOLD

Current Price

$0.14

Market Cap

172.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INGN
KALA
Founded
2001
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
172.4M
172.0M
IPO Year
2013
2017

Fundamental Metrics

Financial Performance
Metric
INGN
KALA
Price
$7.05
$0.14
Analyst Decision
Strong Buy
Buy
Analyst Count
4
3
Target Price
$11.25
$31.50
AVG Volume (30 Days)
261.2K
2.7M
Earning Date
05-07-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
43.42
67.39
EPS
N/A
N/A
Revenue
$348,668,000.00
N/A
Revenue This Year
$8.03
N/A
Revenue Next Year
$7.76
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.86
N/A
52 Week Low
$5.34
$0.15
52 Week High
$9.13
$20.58

Technical Indicators

Market Signals
Indicator
INGN
KALA
Relative Strength Index (RSI) 62.15 29.58
Support Level $6.59 N/A
Resistance Level $7.63 $0.24
Average True Range (ATR) 0.35 0.02
MACD 0.06 0.00
Stochastic Oscillator 75.30 2.06

Price Performance

Historical Comparison
INGN
KALA

About INGN Inogen Inc

Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Share on Social Networks: